Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United States annually. CD8+ T cells that normally kill cancer cells often become ...

In trials, in 708 women, when combined with hormone therapy, the drug doubled the time the cancer took to grow, from 3.6 ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

A new cancer drug called trastuzumab deruxtecan, also known as Enhertu, has just been approved in the UK. This drug is ...

Moreover, combining plant compounds such as curcumin with chemotherapy drugs like cisplatin enhanced treatment efficacy and reduced drug resistance in vitro. The study concluded that medicinal plant ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

NHS England is to review its current policy concerning a decision not to fund a potentially life-extending treatment devised ...

Can a robot help prepare cancer medication in a hospital pharmacy? That's what hospital pharmacist Tjerk Geersing ...

Modern cancer treatments have evolved beyond traditional chemotherapy to include targeted approaches such as immunotherapy, ...